Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
41%
OVERLAP
BY WEIGHT
6
# OF OVERLAPPING
HOLDINGS
PPH
27
HOLDINGS
25%
ALSO IN THNR
THNR
18
HOLDINGS
33%
ALSO IN PPH
SECTOR DRIFT (PPH minus THNR)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PPH |
Weight in THNR |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 23.8% | 15.6% | 15.6% |
 |
NOVO-NORDISK A/S-SPONS ADR | 6.0% | 10.3% | 6.0% |
|
MERCK & CO. INC. | 8.0% | 5.5% | 5.5% |
|
PFIZER INC | 4.7% | 4.9% | 4.7% |
 |
ASTRAZENECA PLC-SPONS ADR | 4.5% | 5.2% | 4.5% |
PPH Overweight Relative to THNR
 |
NOVARTIS AG-ADR | 9.1% |
|
ELI LILLY & CO | 8.3% |
|
GLAXOSMITHKLINE PLC-SPON ADR | 4.8% |
|
JOHNSON & JOHNSON | 4.6% |
|
MCKESSON CORP | 4.6% |
|
BRISTOL-MYERS SQUIBB CO | 4.4% |
 |
SANOFI-AVENTIS-ADR | 4.2% |
|
CENCORA INC | 3.6% |
|
ZOETIS INC | 3.2% |
|
MERCK & CO. INC. | 2.5% |
PPH Underweight Relative to THNR
|
REGENERON PHARMACEUTICALS | -7.9% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -7.3% |
|
AMGEN INC | -7.3% |
|
ROCHE HOLDING LTD | -5.4% |
 |
INNOVENT BIOLOGICS, INC. | -4.5% |
|
SHIONOGI & CO LTD | -4.4% |
|
NOVO-NORDISK A/S-SPONS ADR | -4.3% |
 |
CHINA PHARMACEUTICAL GROUP | -3.6% |
|
HIMS & HERS HEALTH, INC. CLASS A | -3.5% |
|
ZEALAND PHARMA A/S | -3.2% |